Spherix Global Insights

October 26, 2020

Newest Oral DMTs Haven’t Yet Made a Big Impact in the MS World

From: MDedge Neurology By: Bruce Jancin The three oral disease-modifying therapies (DMTs) for multiple sclerosis (MS) approved last year in the United States haven’t made a big splash in…